2021
DOI: 10.1080/17425247.2021.1872542
|View full text |Cite
|
Sign up to set email alerts
|

Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection

Abstract: Introduction:The development of ophthalmic formulations able to deliver hydrophilic and hydrophobic drugs to the inner structures of the eye and restore the preocular tear film has been a leading topic of discussion over the last few years. In this sense, liposomes represent a suitable strategy to achieve these objectives in ocular drug delivery. Areas covered: Knowledge of the different physiological and anatomical structures of the eye, and specially the ocular surface are critical to better understanding an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
37
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 58 publications
(37 citation statements)
references
References 209 publications
(204 reference statements)
0
37
0
Order By: Relevance
“…Moreover, the use of liposomes remarkably improved these effects. The use of new delivery systems such as liposomes is part of novel strategies to avoid early degradation of drugs and regulate their release into the stroma, reducing the frequency of application [21,22,43].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, the use of liposomes remarkably improved these effects. The use of new delivery systems such as liposomes is part of novel strategies to avoid early degradation of drugs and regulate their release into the stroma, reducing the frequency of application [21,22,43].…”
Section: Discussionmentioning
confidence: 99%
“…Liposomes, small vesicles (approximate size of 30-1000 nm) which are prepared with phospholipids, offer an efficient option for PFD drug delivery. Previously, liposomes have been evidenced to increase drug penetration, extend the time in contact with the ocular surface, and to improve the therapeutic effect of topical ophthalmic drugs, thus reducing the frequency of application [21,22]. We anticipate that due to these nanoparticles, PFD penetration will increase the time of interaction with the ocular surface and would improve the therapeutic effect by reducing the frequency of application.…”
Section: Introductionmentioning
confidence: 96%
“…Self-assembled drug carriers that can be prepared in few steps and can encapsulate both small and large active substances, while providing a highly biocompatible, stealth interface are gaining increasing attention for ocular delivery. Although a plethora of novel self-assembled carriers are being tested, polymeric micelles, liposomes, and niosomes have already demonstrated in vivo promising performances [13,16,99,107]. Below, first the variables that drive the formation of these carriers and the main preparation protocols are revisited.…”
Section: Self-assembled Nanocarriers For Topical Diabetic Eye Drugsmentioning
confidence: 99%
“…Liposomes have been widely used as carriers since several decades ago because of their dual capability to simultaneously host hydrophilic and hydrophobic drugs plus the general advantages of passive and active targeting [134,135]. Usefulness of liposomes for topical ophthalmic drug delivery, and especially management of ocular surface diseases, has been recently reviewed [13]. Importantly, the bioinspired structure and composition of liposomes facilitate the fusion with cell membrane at the cornea and conjunctiva surface and drug transfer to cell cytoplasm.…”
Section: Liposomesmentioning
confidence: 99%
See 1 more Smart Citation